This compound is an acetate ester derivative of a steroidal structure and is identified as an impurity associated with abiraterone intermediate production. It is primarily relevant in pharmaceutical manufacturing as a reference standard for quality control.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Abiraterone Impurity N1?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
16-dehydropregnenolone acetate
pharmaceutical intermediate
17-Iodoandrosta-5,16-dien-3beta-ol 3-acetate
pharmaceutical intermediate
6-Bromopicolinic acid
pharmaceutical intermediate
Ethyl 6-bromopyridine-2-carboxylate
pharmaceutical intermediate
Ethyl 6-chloro-2-pyridinecarboxylate
pharmaceutical intermediate
3-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester
pharmaceutical intermediate
20-(Hydroxyimino)pregna-5,16-dien-3-yl acetate
pharmaceutical intermediate
(3beta)-Androsta-5,16-diene-3,17-diol 3-acetate 17-(trifluoromethanesulfonate)
pharmaceutical intermediate
[(3S,8R,9S,10R,13S,14S)-17-ethyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate
FMLBSWHYSGKDKY-CBZNWHGESA-N
CCC1=CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C
Sourcing Abiraterone Impurity N1?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.